Author:
Haumann Friederike,Evangelakos Ioannis,Worthmann Anna,Liebold Imke,Kotschi Stefan,Bischoff Almut Turid,Neuhofer Christiane M.,Schweizer Michaela,Heine Markus,Büchner Boriana,Klopstock Thomas,Prehn Cornelia,Dyar Kenneth Allen,Prokisch Holger,Bosurgi Lidia,Heeren Joerg,Bartelt Alexander,Kubisch Christian,Schlein Christian,
Abstract
AbstractMitochondria warrant cellular energy demands by generating energy equivalents in central carbon metabolism. They are also able to newly synthesize fatty acids via mitochondrial fatty acid synthesis (mtFAS), however, the role of mtFAS for systemic metabolism has been poorly investigated. Here we show that mitochondrial Trans-2-Enoyl-CoA Reductase (MECR), a key enzyme of mtFAS, critically regulates cellular and systemic glucose and lipid homeostasis. In mice, liver or adipose tissue-specific deletion ofMecrreduces the capacity for aerobic glycolytic catabolism and lipogenesis and causes severe mitochondrial as well as fatal parenchymal organ dysfunction. Mechanistically, mtFAS is essential for pyruvate dehydrogenase activity, resulting in low NAD(P)H synthesis and reduced non-mitochondrial lipogenesis. In different human mitochondriopathies we further identify a dysregulation of mtFAS-associated lipid species, thus linking inherited mitochondrial disease to mtFAS. In summary, we introduce mtFAS as an important player in metabolic health via facilitating cellular glycolysis-derived metabolite transformation ultimately linking mtFAS to mitochondrial function and diseases.
Publisher
Cold Spring Harbor Laboratory